Lazaro Nunez
Pediatrics · Coral Gables, FLNPI 1174682090
Payments from drug & device makers
Across 2,654 payments — averaging $1736.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$769K
- Emergent Biosolutions Inc.$685K
- Amgen$683K
- Novo Nordisk AS$343K
- AbbVie$261K
- Romark Laboratories, LC$255K
- plus $1.6M from 20 others
Across 99 payments — averaging $2030.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glenmark Pharmaceuticals Inc., USA$99K
- Ichnos Glenmark Innovation Inc$82K
- Eli Lilly$18K
- Chiesi USA, Inc.$2K
What the payments were for
- Speaking & faculty fees$5,00051%
- Travel & lodging$4,06141%
- Food & beverage$7528%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 92 | $769,130 |
| Emergent Biosolutions Inc. | 709 | $685,282 |
| Amgen | 7 | $683,209 |
| Novo Nordisk AS | 1,183 | $342,573 |
| AbbVie | 65 | $261,331 |
| Romark Laboratories, LC | 1 | $255,080 |
| Ironwood Pharmaceuticals, Inc | 21 | $213,994 |
| Teva Pharmaceuticals USA, Inc. | 3 | $197,600 |
| Esperion Therapeutics, Inc. | 223 | $182,621 |
| Regeneron | 21 | $161,525 |
| Chiesi USA, Inc. | 62 | $140,907 |
| GSK | 27 | $140,113 |
| Sanofi US Services Inc. | 29 | $117,248 |
| Eli Lilly | 89 | $105,372 |
| Boehringer Ingelheim | 26 | $90,720 |
| Johnson & Johnson | 9 | $73,957 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $38,756 |
| Boehringer Ingelheim International GmbH | 52 | $38,179 |
| Acerus Pharmaceuticals Corporation | 6 | $33,099 |
| Merck | 8 | $24,598 |
| Astrazeneca AB | 2 | $23,460 |
| AstraZeneca | 1 | $16,172 |
| Genentech, Inc. | 2 | $6,100 |
| Dermavant Sciences, Inc. | 10 | $3,880 |
| VYNE Pharmaceuticals Inc. | 1 | $3,426 |
| Novartis | 2 | $1,260 |
How this compares
$4,609,592 in reported general payments places this provider in the 95th percentile of 3,964 pediatrics providers in Florida.
Other pediatrics in Coral Gables
- Lilia Roque-GuerreroMiami$39.1M
- Kimberly CruzPompano Beach$19.9M
- Teena HughesTampa$8.2M
- Nora DanielMiami$3.4M
- Hector CorderoNaples$2.6M
- Randall ReeseGulf Breeze$2.3M
- Karen KellyClearwater$2.2M
- Salma ElfakiOrlando$1.9M
- Jorge Lujan-ZilbermanTampa$1.6M
- Julio CasasImmokalee$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.